NCT01544530
Terminated
Phase 2
Feasibility of Mild-to-moderate Therapeutic Hypothermia as an In-vivo Organ Preservation Strategy in Brain-dead Donors
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Organ Transplantation From Brain-dead Donors
- Sponsor
- University of Pittsburgh
- Enrollment
- 4
- Locations
- 1
- Primary Endpoint
- Feasibility and safety
- Status
- Terminated
- Last Updated
- 8 years ago
Overview
Brief Summary
The purpose of this study is to assess the feasibility and safety of mild-to-moderate hypothermia as an in-vivo organ preservation strategy compared to normothermia in 60 brain-dead organ donors.
Investigators
Raghavan Murugan
Associate Professor
University of Pittsburgh
Eligibility Criteria
Inclusion Criteria
- •Age greater than 18 years;pronounced dead as per hospital brain-death criteria
- •Accepted by organ procurement organization for organ donation
- •Subjects within 3 hours of brain death pronouncement
Exclusion Criteria
- •Consent cannot be obtained from authorized representative;mean arterial pressure \< 60 mmHg and/ or more than 2 vasopressor and/or inotrope use
- •Presence of 2nd or 3rd degree heart block
- •Ongoing extracranial hemorrhage
- •International normalized ratio \> 3.0
- •Donors with human-immunodeficiency virus infection
- •Pregnancy
Outcomes
Primary Outcomes
Feasibility and safety
Time Frame: From enrollment to organ procurement (average of 24 hours)
Brain-dead organ donors will be followed from study enrollment up to organ procurement for an average of 24 hours
Secondary Outcomes
- Interleukin-6(Baseline, 6 hours, and at organ procurement (15-24 hrs))
- Actual no. of organs transplanted(At the time of organ procurement)
- Death receptor-5(Baseline, 6 hours, and at organ procurement (15-24 hrs))
- Six-month hospital free survival in recipients(6 months)
- Malondialdehyde(Baseline, 6 hours, and at organ procurement (15-24 hrs))
- Urinary isoprostanes(Baseline, 6 hours, and at organ procurement (15-24 hrs))
- lactate(Baseline, 6 hours, and at organ procurement (15-24 hrs))
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Phase 3
Adjunctive Mild Hypothermia Therapy to Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated With Shock: A Feasibility StudyMyocardial Infarction Complicated With Cardiogenic ShockNCT00846222Assaf-Harofeh Medical Center10
Completed
Not Applicable
Mild Therapeutic Hypothermia During Severe SepsisSepsisNCT01069146University Hospital, Brest20
Completed
Phase 2
Induction of Mild Hypothermia Following Out-of-hospital Cardiac ArrestOut-of-hospital Cardiac ArrestNCT00391469University of Washington1,359
Withdrawn
Not Applicable
Reperfusion With Cooling in Cerebral Acute Ischemia IIIschemic StrokeHypothermiaNCT01728649WellStar Health System
Completed
Phase 1
Reperfusion With Cooling in Cerebral Acute IschemiaStroke, AcuteNCT01585597Emory University20